SCHEMBL6711947

SCHEMBL6711947

Cn1c(C(=O)Nc2ccc(Br)cc2-c2noc(=O)[nH]2)cc2c(Br)cc(Br)c(NC(=O)Cc3ccccc3)c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.35
RXFP1 Q9HBX9 2/20 0.34
HIF1A Q16665 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KMT2A Q03164 4/20 0.34
GAA P10253 3/20 0.33
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
ADORA2B P29275 1/20 0.33
MEN1 O00255 3/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
GALR3 O60755 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA5A P35218 1/20 0.32
CA7 P43166 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709860 0.93 GRIK1 (0.39) GRIK1RXFP1KMT2AGAATP53
SCHEMBL6710409 0.91 GRIK1 (0.36) GRIK1RXFP1HIF1ANPSR1KMT2A
SCHEMBL6710244 0.91 PARP14 (0.34) GRIK1GAATP53MAPTADORA2B
SCHEMBL6708003 0.85 KMT2A (0.32) GRIK1RXFP1HIF1ANPSR1KMT2A
SCHEMBL6710049 0.85 HIF1A (0.39) RXFP1HIF1ANPSR1KMT2AGAA
SCHEMBL6710187 0.84 F11 (0.40) GRIK1RXFP1KMT2AGAATP53
SCHEMBL6710260 0.82 GRIK1 (0.38) GRIK1RXFP1HIF1ANPSR1KMT2A
SCHEMBL6919458 0.82 KDM4E (0.34) GRIK1HIF1AGAAALDH1A1KDM4E
SCHEMBL6709930 0.82 PARP14 (0.37) GAATP53MAPTADORA2BALDH1A1
SCHEMBL6708833 0.79 GRIK1 (0.38) GRIK1RXFP1HIF1ANPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885RXFP1 3836/4885HIF1A 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.